Osaic Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Buy |
1,157
+139
| +14% | +$12.9K | ﹤0.01% | 4124 |
|
|
2025
Q1 | $134K | Sell |
1,018
-1,328
| -57% | -$175K | ﹤0.01% | 3956 |
|
|
2024
Q4 | $126K | Buy |
2,346
+692
| +42% | +$37.2K | ﹤0.01% | 3994 |
|
|
2024
Q3 | $121K | Sell |
1,654
-288
| -15% | -$21.1K | ﹤0.01% | 4078 |
|
|
2024
Q2 | $133K | Buy |
1,942
+892
| +85% | +$61.1K | ﹤0.01% | 3904 |
|
|
2024
Q1 | $72.7K | Sell |
1,050
-12,152
| -92% | -$841K | ﹤0.01% | 4465 |
|
|
2023
Q4 | $945K | Buy |
13,202
+8,145
| +161% | +$583K | ﹤0.01% | 2577 |
|
|
2023
Q3 | $263K | Buy |
5,057
+1,037
| +26% | +$54K | ﹤0.01% | 3789 |
|
|
2023
Q2 | $254K | Buy |
4,020
+461
| +13% | +$29.2K | ﹤0.01% | 3709 |
|
|
2023
Q1 | $193K | Buy |
3,559
+445
| +14% | +$24.1K | ﹤0.01% | 3895 |
|
|
2022
Q4 | $166K | Sell |
3,114
-194
| -6% | -$10.3K | ﹤0.01% | 4020 |
|
|
2022
Q3 | $154K | Sell |
3,308
-13,624
| -80% | -$634K | ﹤0.01% | 3997 |
|
|
2022
Q2 | $966K | Sell |
16,932
-7,653
| -31% | -$437K | ﹤0.01% | 2303 |
|
|
2022
Q1 | $1.5M | Buy |
24,585
+23,017
| +1,468% | +$1.41M | ﹤0.01% | 2186 |
|
|
2021
Q4 | $82K | Buy |
1,568
+608
| +63% | +$31.8K | ﹤0.01% | 4740 |
|
|
2021
Q3 | $36K | Sell |
960
-146
| -13% | -$5.48K | ﹤0.01% | 5356 |
|
|
2021
Q2 | $45K | Buy |
1,106
+395
| +56% | +$16.1K | ﹤0.01% | 5116 |
|
|
2021
Q1 | $24K | Sell |
711
-25
| -3% | -$844 | ﹤0.01% | 5348 |
|
|
2020
Q4 | $23K | Sell |
736
-117
| -14% | -$3.66K | ﹤0.01% | 5043 |
|
|
2020
Q3 | $22K | Sell |
853
-1,510
| -64% | -$38.9K | ﹤0.01% | 4848 |
|
|
2020
Q2 | $60K | Buy |
2,363
+213
| +10% | +$5.41K | ﹤0.01% | 4054 |
|
|
2020
Q1 | $33K | Buy |
+2,150
| New | +$33K | ﹤0.01% | 4277 |
|